These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. BRAFi-associated panniculitis - an emerging side effect with a variable histological picture: report of two cases and review of the literature. Ferreira J; Toda-Brito H; Moura MC; Sachse MF; Costa-Rosa J J Cutan Pathol; 2017 Mar; 44(3):307-309. PubMed ID: 27976808 [No Abstract] [Full Text] [Related]
5. Panniculitis in patients treated with BRAF inhibitors: a case series. Choy B; Chou S; Anforth R; Fernández-Peñas P Am J Dermatopathol; 2014 Jun; 36(6):493-7. PubMed ID: 24879511 [TBL] [Abstract][Full Text] [Related]
7. Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma. Anforth RM; Blumetti TC; Kefford RF; Sharma R; Scolyer RA; Kossard S; Long GV; Fernandez-Peñas P Br J Dermatol; 2012 Nov; 167(5):1153-60. PubMed ID: 22804352 [TBL] [Abstract][Full Text] [Related]
8. Clinical observation of panniculitis in two patients with BRAF-mutated metastatic melanoma treated with a combination of a BRAF inhibitor and a MEK inhibitor. Galliker NA; Murer C; Kamarashev J; Dummer R; Goldinger SM Eur J Dermatol; 2015 Apr; 25(2):177-80. PubMed ID: 25788221 [TBL] [Abstract][Full Text] [Related]
9. Cutaneous adverse effects of BRAF inhibitors in metastatic malignant melanoma, a prospective study in 20 patients. Vanneste L; Wolter P; Van den Oord JJ; Stas M; Garmyn M J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):61-8. PubMed ID: 24661317 [TBL] [Abstract][Full Text] [Related]
10. Cutaneous granulomatous panniculitis and sarcoidal granulomatous papular eruption in a patient with metastatic melanoma treated with a BRAF inhibitor. Leal L; Agut-Busquet E; Romani J; Sabat M; Yebenes M; Saez A; Luelmo J J Dermatol; 2016 Jun; 43(6):715-6. PubMed ID: 26777901 [No Abstract] [Full Text] [Related]
11. Granulomatous nephritis and dermatitis in a patient with BRAF V600E mutant metastatic melanoma treated with dabrafenib and trametinib. Jansen YJ; Janssens P; Hoorens A; Schreuer MS; Seremet T; Wilgenhof S; Neyns B Melanoma Res; 2015 Dec; 25(6):550-4. PubMed ID: 26512791 [TBL] [Abstract][Full Text] [Related]
20. Dabrafenib in an elderly patient with metastatic melanoma and BRAF V600R mutation: a case report. Casadevall D; Vidal J; Gallardo F; Zuccarino F; Arumí-Uría M; Dalmases A; Bellosillo B; Montagut C J Med Case Rep; 2016 Jun; 10(1):158. PubMed ID: 27255157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]